The program reviews current scientific evidence surrounding obesity-related inflammation in psoriasis and psoriatic arthritis while examining evolving therapeutic strategies for patients with overlapping inflammatory conditions. Discussions highlight emerging perspectives on disease burden, treatment considerations, and multidisciplinary approaches to patient care.
Faculty: Mark Lebwohl, MD April W. Armstrong, MD, MPH Brad Glick, DO, MPH